Validation of a Trans-Ancestry Polygenic Risk Score for Type 2 Diabetes in Diverse Populations
Marguerite Ryan Irvin,
Hemant K. Tiwari,
Brittney H. Davis,
Mark J O'Connor,
Miriam S Udler,
Karmel W Choi,
Ayme D. Miles,
Yen-Chen Anne Feng,
James J. Cimino,
Scott T. Weiss,
Maggie C. Y. Ng,
Jordan W. Smoller,
Matthew S. Lebo,
James B Meigs,
Nita A. Limdi,
Elizabeth W. Karlson
Posted 15 Sep 2021
medRxiv DOI: 10.1101/2021.09.11.21263413
Posted 15 Sep 2021
Type 2 diabetes (T2D) is a worldwide scourge caused by both genetic and environmental risk factors that disproportionately afflicts communities of color. Leveraging existing large-scale genome-wide association studies (GWAS), polygenic risk scores (PRS) have shown promise to complement established clinical risk factors and intervention paradigms, and improve early diagnosis and prevention of T2D. However, to date, T2D PRS have been most widely developed and validated in individuals of European descent. Comprehensive assessment of T2D PRS in non-European populations is critical for an equitable deployment of PRS to clinical practice that benefits global populations. Here we integrate T2D GWAS in European, African American and East Asian populations to construct a trans-ancestry T2D PRS using a newly developed Bayesian polygenic modeling method, and evaluate the PRS in the multi-ethnic eMERGE study, four African American cohorts, and the Taiwan Biobank. The trans-ancestry PRS was significantly associated with T2D status across the ancestral groups examined, and the top 2% of the PRS distribution can identify individuals with an approximately 2.5-4.5 fold of increase in T2D risk, suggesting the potential of using the trans-ancestry PRS as a meaningful index of risk among diverse patients in clinical settings. Our efforts represent the first step towards the implementation of the T2D PRS into routine healthcare.
- Downloaded 280 times
- Download rankings, all-time:
- Site-wide: 110,708
- In genetic and genomic medicine: 579
- Year to date:
- Site-wide: 27,388
- Since beginning of last month:
- Site-wide: 1,431
Downloads over time
Distribution of downloads per paper, site-wide
- 27 Nov 2020: The website and API now include results pulled from medRxiv as well as bioRxiv.
- 18 Dec 2019: We're pleased to announce PanLingua, a new tool that enables you to search for machine-translated bioRxiv preprints using more than 100 different languages.
- 21 May 2019: PLOS Biology has published a community page about Rxivist.org and its design.
- 10 May 2019: The paper analyzing the Rxivist dataset has been published at eLife.
- 1 Mar 2019: We now have summary statistics about bioRxiv downloads and submissions.
- 8 Feb 2019: Data from Altmetric is now available on the Rxivist details page for every preprint. Look for the "donut" under the download metrics.
- 30 Jan 2019: preLights has featured the Rxivist preprint and written about our findings.
- 22 Jan 2019: Nature just published an article about Rxivist and our data.
- 13 Jan 2019: The Rxivist preprint is live!